Genetec Technology Berhad Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Genetec Technology Berhad hat ein Gesamteigenkapital von MYR496.7M und eine Gesamtverschuldung von MYR14.8M, wodurch sich der Verschuldungsgrad auf 3% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen MYR567.7M bzw. MYR71.0M. Genetec Technology Berhad Das EBIT des Unternehmens beträgt MYR72.7M, so dass der Zinsdeckungsgrad 430.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von MYR164.4M.

Wichtige Informationen

3.0%

Verhältnis von Schulden zu Eigenkapital

RM 14.80m

Verschuldung

Zinsdeckungsgrad	430.5x
Bargeld	RM 164.40m
Eigenkapital	RM 496.73m
Gesamtverbindlichkeiten	RM 70.98m
Gesamtvermögen	RM 567.71m

Jüngste Berichte zur Finanzlage

Recent updates

Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Oct 23

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

Sep 22

Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

Aug 27

Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

Aug 19

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Aug 06

Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

Feb 26

Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

Jan 15

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Sep 22

Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

Feb 08

Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

Dec 28

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

Nov 17

Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Aug 16

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

Jul 21

Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 30

Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price

Apr 28

Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)

Mar 23

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Feb 24

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Nov 04

The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

Sep 08

Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Aug 05

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

Jul 30

Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Jun 11

How Well Is Genetec Technology Berhad (KLSE:GENETEC) Allocating Its Capital?

Feb 10

Why Genetec Technology Berhad's (KLSE:GENETEC) CEO Pay Matters

Jan 14

Here's Why Genetec Technology Berhad (KLSE:GENETEC) Can Manage Its Debt Responsibly

Dec 24

Genetec Technology Berhad's (KLSE:GENETEC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

Dec 03

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: GENETECDie kurzfristigen Aktiva des Unternehmens (MYR422.3M) übersteigen seine kurzfristigen Passiva (MYR62.1M).

Langfristige Verbindlichkeiten: GENETECDie kurzfristigen Vermögenswerte des Unternehmens (MYR422.3M) übersteigen seine langfristigen Verbindlichkeiten (MYR8.8M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: GENETEC über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: GENETEC Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 19.1% auf 3% zurückgegangen.

Schuldendeckung: GENETECDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (228.3%).

Zinsdeckung: GENETECDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (430.5x Coverage) gut gedeckt.

Genetec Technology Berhad Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 6/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Recent updates

New major risk - Share price stability

Tan Moon Teik agreed to acquire an additional 51% stake in Clt Engineering Sdn Bhd from Genetec Technology Berhad (KLSE:GENETEC) for MYR 21.6 million.

Tan Moon Teik agreed to acquire an additional 51% stake in Clt Engineering Sdn Bhd from Genetec Technology Berhad (KLSE:GENETEC) for MYR 21.6 million.

Full year 2024 earnings: EPS and revenues miss analyst expectations

Genetec Technology Berhad, Annual General Meeting, Nov 26, 2024

Genetec Technology Berhad (KLSE:GENETEC) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Investor sentiment improves as stock rises 20%

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

New minor risk - Share price stability

New minor risk - Dividend sustainability

Upcoming dividend of RM0.02 per share

Genetec Technology Berhad Declares Interim Single-Tier Dividend for the Financial Period Ended 30 June 2024, Payable on 4 October 2024

Genetec Technology Berhad Declares Interim Single-Tier Dividend for the Financial Period Ended 30 June 2024, Payable on 4 October 2024

Genetec Technology Berhad (KLSE:GENETEC) Analysts Are More Bearish Than They Used To Be

Price target decreased by 7.4% to RM3.75

Investor sentiment deteriorates as stock falls 17%

Not Many Are Piling Into Genetec Technology Berhad (KLSE:GENETEC) Stock Yet As It Plummets 27%

Is Genetec Technology Berhad (KLSE:GENETEC) A Risky Investment?

Now 21% undervalued after recent price drop

Full year 2024 earnings released: EPS: RM0.10 (vs RM0.097 in FY 2023)

Now 23% overvalued after recent price rise

Third quarter 2024 earnings released: EPS: RM0.031 (vs RM0.019 in 3Q 2023)

Genetec Technology Berhad's (KLSE:GENETEC) P/E Still Appears To Be Reasonable

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Slowing Rates Of Return At Genetec Technology Berhad (KLSE:GENETEC) Leave Little Room For Excitement

Second quarter 2024 earnings released: EPS: RM0.025 (vs RM0.037 in 2Q 2023)

Genetec Technology Berhad's (KLSE:GENETEC) CEO Will Probably Have Their Compensation Approved By Shareholders

Genetec Technology Berhad, Annual General Meeting, Sep 29, 2023

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2023 earnings released: EPS: RM0.11 (vs RM0.083 in FY 2022)

Genetec Technology Berhad Appoints Dato' Jeeventhiran A/L Ramanaidu as Independent and Non-Executive Member of Remuneration Committee

Third quarter 2023 earnings released: EPS: RM0.019 (vs RM0.028 in 3Q 2022)

Consensus EPS estimates fall by 11%

Genetec Technology Berhad has completed a Follow-on Equity Offering in the amount of MYR 177.99203 million.

Does Genetec Technology Berhad (KLSE:GENETEC) Deserve A Spot On Your Watchlist?

Price target increased to RM4.50

Genetec Technology Berhad (KLSE:GENETEC) Is Investing Its Capital With Increasing Efficiency

Second quarter 2023 earnings released: EPS: RM0.037 (vs RM0.025 in 2Q 2022)

Does Genetec Technology Berhad (KLSE:GENETEC) Have A Healthy Balance Sheet?

Investors Shouldn't Overlook Genetec Technology Berhad's (KLSE:GENETEC) Impressive Returns On Capital

Full year 2022 earnings: EPS misses analyst expectations

Genetec Technology Berhad, Annual General Meeting, Aug 29, 2022

Investor sentiment improved over the past week

Genetec Technology Berhad (KLSE:GENETEC) Has A Pretty Healthy Balance Sheet

Now 20% undervalued after recent price drop

Price target decreased to RM4.07

Genetec Technology Berhad (KLSE:GENETEC) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to RM4.50

Investor sentiment improved over the past week

Genetec Technology Berhad's (KLSE:GENETEC) Intrinsic Value Is Potentially 93% Above Its Share Price

Why We Like The Returns At Genetec Technology Berhad (KLSE:GENETEC)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Genetec Technology Berhad Appoints Dato' Jeeventhiran A/L Ramanaidu as Independent and Non Executive Director

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 14%

Investor sentiment deteriorated over the past week

Genetec Technology Berhad (KLSE:GENETEC) Seems To Use Debt Quite Sensibly

Second quarter 2022 earnings released: EPS RM0.32 (vs RM0.062 in 2Q 2021)

The CEO Of Genetec Technology Berhad (KLSE:GENETEC) Might See A Pay Rise On The Horizon

Genetec Technology Berhad's (KLSE:GENETEC) Robust Earnings Are Not All Good News For Shareholders

Genetec Technology Berhad's (KLSE:GENETEC) Returns On Capital Are Heading Higher

First quarter 2022 earnings released: EPS RM0.16 (vs RM0.049 loss in 1Q 2021)

Genetec Technology Berhad has completed a Follow-on Equity Offering in the amount of MYR 7.839324 million.

Is Genetec Technology Berhad (KLSE:GENETEC) Using Debt In A Risky Way?

Full year 2021 earnings released: RM0.097 loss per share (vs RM0.004 loss in FY 2020)